Compounds > paclitaxel
Page last updated: 2024-08-23

paclitaxel and Milk-Alkali Syndrome

paclitaxel has been researched along with Milk-Alkali Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, T; Konishi, I; Mandai, M; Matsumura, N; Mikami, Y; Takamatsu, S1
Sawada, M; Uehara, T1
Inoue, K; Iwase, H; Kawazoe, T; Nagamoto, N; Nakahara, O; Ohsako, T; Sakamoto, N; Yamamoto, Y; Yoshida, Y1
Buzdar, A; Cohen, PR; Dhingra, K; Gagel, R; Holmes, F; Payne, JY1
Kunisue, H; Kurebayashi, J; Shimozuma, K; Sonoo, H; Tanaka, K; Udagawa, K; Yamamoto, S; Yamamoto, Y1

Other Studies

5 other study(ies) available for paclitaxel and Milk-Alkali Syndrome

ArticleYear
Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component.
    The journal of obstetrics and gynaecology research, 2014, Volume: 40, Issue:1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Carcinosarcoma; Chemotherapy, Adjuvant; Endometrium; Female; Humans; Hypercalcemia; Hysterectomy; Ovariectomy; Paclitaxel; Paraneoplastic Syndromes; Salpingectomy; Treatment Outcome; Uterine Hemorrhage; Uterine Neoplasms; Uterus

2014
A case of ovarian cancer associated with hypercalcemia.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:10

    Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Calcium; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Hypercalcemia; Hysterectomy; Lymph Node Excision; Magnetic Resonance Imaging; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Tomography, X-Ray Computed

2008
[Two cases of stage IV breast cancer with severe hypercalcemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2

    Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Goserelin; Humans; Hypercalcemia; Imidazoles; Leuprolide; Lymph Nodes; Lymphatic Metastasis; Paclitaxel; Quality of Life; Tamoxifen; Zoledronic Acid

2006
Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia.
    Southern medical journal, 1996, Volume: 89, Issue:5

    Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Eruptions; Erythema Multiforme; Female; Humans; Hyperbilirubinemia; Hypercalcemia; Liver Neoplasms; Middle Aged; Mouth Diseases; Neoplasm Proteins; Paclitaxel; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Proteins; Vaginal Diseases

1996
[A case of advanced breast cancer associated with humoral hypercalcemia that responded to medroxyprogesterone acetate and docetaxel].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:7

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Hypercalcemia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Paclitaxel; Taxoids

2000